OR23-05 Log-term Efficacy And Safety Of Transcon PTH In Adults With Hypoparathyroidism: 52-week Results From The Open-label Extension Of The Phase 3 Pathway Trial

por Clarke, Bart, Aziz Khan, Aliya, Ruth Rubin, Mishaela, Schwarz, Peter E, Vokes, Tamara J, Shoback, Dolores M, Gagnon, Claudia, Palermo, Andrea, Abbott, Lisa G, Hofbauer, Lorenz C, Kohlmeier, Lynn, Cetani, Filomena, Phil, Susanne, An, Xuebei, Raymond Smith, Alden, Lai, Bryant, Le, John, Ukena, Jenny, Sibley, Christopher, Shu, Aimee, Rejnmark, Lars
Publicado 2023